Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.
Intermittent Hypoxic-hyperoxic Training for the Rehabilitation in Patients With Cardiovascular Pathology After COVID-19 Infection.
Sponsor: I.M. Sechenov First Moscow State Medical University
Listed as NCT05379608, this NA trial focuses on Arrhythmia and COVID-19 and remains completed. Sponsored by I.M. Sechenov First Moscow State Medical University, it has been updated 6 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Aug 2025 — Sep 2025 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Aug 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Jun 2022 — Dec 2023 [monthly]
Recruiting NA
First recorded
Dec 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- I.M. Sechenov First Moscow State Medical University
For direct contact, visit the study record on ClinicalTrials.gov .